Risk factors,prognostic predictors,and nomograms for pancreatic cancer patients with initially diagnosed synchronous liver metastasis

被引:0
|
作者
Bi-Yang Cao [1 ,2 ]
Fang Tong [1 ]
Le-Tian Zhang [1 ,2 ]
Yi-Xin Kang [1 ,2 ]
Chen-Chen Wu [1 ,2 ]
Qian-Qian Wang [1 ]
Wei Yang [1 ]
Jing Wang [1 ]
机构
[1] Department of Radiation Oncology,First Medical Center of Chinese PLA General Hospital
[2] Medical School of Chinese PLA
关键词
Pancreatic neoplasms; Neoplasm metastasis; Liver; Prognosis; Nomograms; Surveillance; Epidemiology; and End Result program;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND Liver metastasis(LM) remains a major cause of cancer-related death in patients with pancreatic cancer(PC) and is associated with a poor prognosis. Therefore,identifying the risk and prognostic factors in PC patients with LM(PCLM) is essential as it may aid in providing timely medical interventions to improve the prognosis of these patients. However, there are limited data on risk and prognostic factors in PCLM patients.AIM To investigate the risk and prognostic factors of PCLM and develop corresponding diagnostic and prognostic nomograms.METHODS Patients with primary PC diagnosed between 2010 and 2015 were reviewed from the Surveillance, Epidemiology, and Results Database. Risk factors were identified using multivariate logistic regression analysis to develop the diagnostic mode.The least absolute shrinkage and selection operator Cox regression model was used to determine the prognostic factors needed to develop the prognostic model.The performance of the two nomogram models was evaluated using receiver operating characteristic(ROC) curves, calibration plots, decision curve analysis(DCA), and risk subgroup classification. The Kaplan-Meier method with a logrank test was used for survival analysis.RESULTS We enrolled 33459 patients with PC in this study. Of them, 11458(34.2%) patients had LM at initial diagnosis. Age at diagnosis, primary site, lymph node metastasis, pathological type, tumor size,and pathological grade were identified as independent risk factors for LM in patients with PC.Age > 70 years, adenocarcinoma, poor or anaplastic differentiation, lung metastases, no surgery,and no chemotherapy were the independently associated risk factors for poor prognosis in patients with PCLM. The C-index of diagnostic and prognostic nomograms were 0.731 and 0.753,respectively. The two nomograms could accurately predict the occurrence and prognosis of patients with PCLM based on the observed analysis results of ROC curves, calibration plots, and DCA curves. The prognostic nomogram could stratify patients into prognostic groups and perform well in internal validation.CONCLUSION Our study identified the risk and prognostic factors in patients with PCLM and developed corresponding diagnostic and prognostic nomograms to help clinicians in subsequent clinical evaluation and intervention. External validation is required to confirm these results.
引用
收藏
页码:128 / 142
页数:15
相关论文
共 50 条
  • [41] Prognostic factors in endometrial cancer patients with bone metastasis
    Basarir, Zehra Ozturk
    Karaca, Mustafa Onur
    Balaban, Kamil
    Basarir, Kerem
    Yildiz, Huseyin Yusuf
    JOINT DISEASES AND RELATED SURGERY, 2023, 34 (01) : 207 - 214
  • [42] Prognostic factors in patients with advanced pancreatic cancer treated with systemic chemotherapy
    Ishii, H
    Okada, S
    Nose, H
    Yoshimori, M
    Aoki, K
    Okusaka, T
    PANCREAS, 1996, 12 (03) : 267 - 271
  • [43] Establishment of nomogram of early death in elderly pancreatic cancer patients with liver metastasis
    Wu, Yang
    Li, Tian
    Zhang, Runbing
    Shi, Tingting
    Wang, Shunna
    Zhu, Lingling
    Zhang, Yani
    Zheng, Xiaofeng
    Yu, Xiaohui
    Zhang, Jiucong
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [44] Estimating the risk of brain metastasis for patients newly diagnosed with cancer
    Miccio, Joseph A.
    Tian, Zizhong
    Mahase, Sean S.
    Lin, Christine
    Choi, Serah
    Zacharia, Brad E.
    Sheehan, Jason P.
    Brown, Paul D.
    Trifiletti, Daniel M.
    Palmer, Joshua D.
    Wang, Ming
    Zaorsky, Nicholas G.
    COMMUNICATIONS MEDICINE, 2024, 4 (01):
  • [45] Prognostic factors in patients with breast cancer and brain metastasis as the first site of recurrence
    Mohar-Betancourt, Alejandro
    Alvarado-Miranda, Alberto
    Alejandro Torres-Dominguez, Juan
    Cabrera, Paula
    Lara-Medina, Fernando
    Sadid Villarreal-Gomez, Yaudim
    Reynoso-Noveron, Nancy
    SALUD PUBLICA DE MEXICO, 2018, 60 (02): : 141 - 150
  • [46] Survival outcomes for patients with colorectal cancer with synchronous liver only metastasis
    Shepherdson, Mia
    Kilburn, Daniel
    Ullah, Shahid
    Price, Timothy
    Karapetis, Christos S.
    Nguyen, Peter
    Townsend, Amanda
    Padbury, Robert
    Piantadosi, Cynthia
    Maddern, Guy
    Carruthers, Scott
    Roder, David
    Sorich, Michael
    Roy, Amitesh C.
    ANZ JOURNAL OF SURGERY, 2023, 93 (7-8) : 1847 - 1853
  • [47] Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis
    Yang, Zifeng
    Li, Yong
    Qin, Xiusen
    Lv, Zejian
    Wang, Huaiming
    Wu, Deqing
    Yuan, Zixu
    Wang, Hui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [48] Prognostic factors and novel nomograms for overall survival and cancer specific survival of malignant ovarian cancer patients with bone metastasis: A SEER-based study
    Luo, Ling
    Xu, Ningze
    Liu, Yuyang
    Zhong, Sen
    Yang, Sheng
    Chen, Xi
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 165 (01) : 176 - 187
  • [49] Prediction model of liver metastasis risk in patients with gastric cancer: A population-based study
    Huang, Fang
    Fang, Meihua
    MEDICINE, 2023, 102 (39) : E34702
  • [50] Clinicopathological features and treatment outcomes in patients with initially diagnosed stage IV breast cancer bone metastasis
    Sun, Jianna
    Kong, Lingjun
    Ren, Chongxi
    Liu, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11645 - 11656